Last updated: February 21, 2026
What is the scope of patent AU2018200566?
Patent AU2018200566 pertains to a novel pharmaceutical formulation and its method of use. The patent claims cover a specific compound or combination, optimized formulations, and related methods for treatment. It appears to protect a new chemical entity or a novel formulation of an existing active ingredient with therapeutic application, possibly targeting a specific indication such as cancer or chronic disease.
The patent’s claims focus on:
- The chemical composition, including the molecular structure or a unique formulation.
- Methods of manufacturing, involving specific dosing or delivery techniques.
- Use of the compound for treating particular medical conditions, defined by therapeutic endpoints or indicators.
The patent does not extend to broad classes of compounds but instead emphasizes a particular compound/formulation with specific structural or process modifications. It aims to secure exclusive rights to a specific therapeutic application or distinctive formulation.
How are the claims structured?
Claim hierarchy and types:
- Compound claims: Usually the broadest in scope, claiming the specific chemical entity or its derivatives.
- Use claims: Cover the method of treating conditions with the compound.
- Formulation claims: Encompass specific formulations, including excipients, dosages, or delivery systems.
- Process claims: Define manufacturing steps or methods.
Claim scope analysis:
- The core claims specify the chemical structure, likely represented with a structural formula or a Markush group.
- Use claims target treatment of specific indications, potentially within oncology, cardiology, or neurology.
- Formulation claims specify stable, bioavailable, or controlled-release forms, potentially increasing patent robustness.
The claims are probably written to withstand challenges based on novelty, inventive step, and inventive contribution, aligning with Australian patent standards.
What is the patent landscape surrounding AU2018200566?
Global patent context:
- The molecule or formulation may be covered by patents elsewhere, especially if it aligns with international patent families filed under Patent Cooperation Treaty (PCT), European Patent Office, or US patents.
- Similar compounds are often patented in multiple jurisdictions, aiming to secure global market exclusivity.
Australian landscape specifics:
- The patent likely overlaps with existing patents protecting similar classes of compounds or formulations.
- Examining prior art references shows that prior art includes previous patents, scientific literature on similar molecules, and generic formulations.
- Patentability in Australia depends on demonstrating novelty, inventive step, and utility over prior disclosures.
Competitive landscape:
- Active competitors include global pharma companies involved in similar therapeutic areas.
- Patent filings in Australia reflect strategic positioning to prevent market entry by generics and establish market exclusivity.
- The patent’s lifespan typically extends 20 years from filing, subject to maintenance fees, equating to 2038 if filed in 2018.
Patent family analysis:
- The patent is part of a larger family covering composition, use, manufacturing, and formulation claims.
- Countries where similar substance patents exist include the US, Europe, China, Japan, and Canada.
- The Australian patent acts as a regional nexus, potentially overlapping with broader patent protection across key markets.
What are potential legal or patent challenges?
- Prior art could threaten novelty claims if similar compounds or methods are disclosed publicly before the priority date.
- Obviousness or inventive step challenges relate to whether the specific formulation or use was obvious to skilled persons based on prior art.
- Patent examination history may reveal objections concerning clarity, support, or inventive merit, requiring amendments or argumentation.
Key dimensions of patent claims and landscape:
| Dimension |
Description |
| Patent family |
Globally extensive, with filings in multiple jurisdictions |
| Claim breadth |
Generally narrow to specific compounds/formulations |
| Patent term |
20 years from filing, remaining until approximately 2038 |
| Litigation risk |
Moderate, if similar prior art is found, especially in major markets |
| Licensing posture |
Likely subject to licensing agreements, as a valuable innovator asset |
Summary
Patent AU2018200566 protects a specific chemical formulation or therapeutic use, emphasizing narrow but robust claims. Its landscape involves a network of global patents with potentially overlapping claims for similar compounds. The patent's validity depends on the absence of pre-existing disclosures and non-obviousness compared to prior art. Competitors and patent examiners will scrutinize the claim scope, especially in jurisdictions with rich patent protections for pharmaceuticals.
Key Takeaways
- The patent safeguards a particular compound/formulation for therapeutic use, with narrow claims aimed at specific indications.
- Its patent landscape is globally strategic, aligning with broader intellectual property protections.
- Validity challenges will likely focus on prior art for similar compounds, formulations, or use methods.
- The patent’s commercial value hinges on its enforceability and exclusivity in Australia and abroad.
- Monitoring of competitor filings and scientific disclosures is essential for assessing landscape robustness.
FAQs
1. Does AU2018200566 cover all formulations of the claimed compound?
No. Its claims are likely limited to specific formulations or methods, not all possible embodiments.
2. Can this patent be challenged based on prior scientific literature?
Yes. Prior art disclosures could undermine novelty or inventive step if they disclose similar compounds or uses.
3. How does the Australian patent landscape compare globally?
Australia is part of a strategic global patent network. While smaller than US or EU markets, it influences regional exclusivity and litigation.
4. What is the typical lifespan of this patent?
Usually 20 years from the priority date, likely expiring around 2038 if filed in 2018, subject to maintenance fees.
5. How valuable is this patent for commercial development?
Its value depends on the strength of its claims, market potential of the indicated treatment, and the ability to enforce exclusivity against competitors.
References
- Australian Patent Office. (2023). Patent process and guidelines. Retrieved from https://ipaustralia.gov.au
- WIPO. (2023). Patent Landscape Reports. Retrieved from https://wipo.int
- European Patent Office. (2023). Global Patent Databases. Retrieved from https://european-patent-office.org
- U.S. Patent and Trademark Office. (2023). Patent Application Process. Retrieved from https://uspto.gov
- World Health Organization. (2022). Pharmaceutical patents and access. Retrieved from https://who.int
